The IND application for this pilot trial to evaluate oral growth hormone secretagogue, LUM-201, in…
– $209.7 Million Cash and Cash Equivalents at March 31, 2022 – – Over 120…
Strategic Expansion of Turning Point Precision Oncology Portfolio TPX-4589 (LM-302) Currently in Two Ongoing Phase…
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from…
Developed in partnership with J.P. Morgan and Johnson & Johnson Innovation, the Conference will bring…
Nes-Ziona, Israel, May 05, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
– Biotechnology Chief Financial Officer and highly regarded former healthcare investment banker brings decades of…
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S….
Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE…
Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma NEW YORK, May 05, 2022…
New Process Improves Quality and Lowers Cost Fremont, CA, May 05, 2022 (GLOBE NEWSWIRE) —…
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
JERSEY CITY, N.J., May 05, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
NEWTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
IRVINE, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic…
Scientific Advisory Board of leading experts in oncolytic adenoviruses and gene therapies strengthens transformative clinical…
WESTLAKE VILLAGE, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
NEW ORLEANS and LONDON, May 05, 2022 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
SEATTLE, May 05, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…